| Dr Mark Kelly, DO | |
|
1220 Jefferson St, Laurel, MS 39440-4355 | |
| (601) 426-4507 | |
| (601) 426-4228 |
| Full Name | Dr Mark Kelly |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1220 Jefferson St, Laurel, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457394090 | NPI | - | NPPES |
| 00124357 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 17057 (Mississippi) | Primary |
| Entity Name | South Central Clinics, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801226287 PECOS PAC ID: 4385876655 Enrollment ID: O20140515000834 |
News Archive
Most men start to go bald in middle age, with about 80% of men having some hair loss by the age of 70. Male pattern baldness is the most common type of hair loss for men, the National Institute of Health said. Symptoms include a thinning of hair at the hairline, eventually creating a U-shaped or horseshoe pattern of hair on both sides of the head. The male sex hormone testosterone plays a key role, as do genetic factors. They cause the hair follicles to shrink, eventually becoming so small that they are invisible, leading to the appearance of baldness. While treatment is not necessary, side effects including psychological stress and loss of self-esteem due to change in appearance can be experienced.
Spinal cord ischemia/reperfusion injury is a stress injury to the spinal cord. Therefore, research on the expression of stress-related protein in neurons could be of great significance for the pathological mechanism and control measures for spinal cord ischemia/reperfusion injury.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
The Association of Rehabilitation Nurses (ARN) presented Kathleen Brewer-Smyth, PhD RN CRRN, with the 2013 ARN Doctorate-Prepared Researcher Role Award. Dr. Brewer-Smyth received her award at the 39th Annual ARN Educational Conference, held October 2-5 in Charlotte, NC.
Actavis Group has announced that it has launched Terbinafine hydrochloride tablets in the U.S. Distribution of the product will commence immediately.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Kelly, DO Po Box 247, Laurel, MS 39441-0247 Ph: (601) 399-6167 | Dr Mark Kelly, DO 1220 Jefferson St, Laurel, MS 39440-4355 Ph: (601) 426-4507 |
News Archive
Most men start to go bald in middle age, with about 80% of men having some hair loss by the age of 70. Male pattern baldness is the most common type of hair loss for men, the National Institute of Health said. Symptoms include a thinning of hair at the hairline, eventually creating a U-shaped or horseshoe pattern of hair on both sides of the head. The male sex hormone testosterone plays a key role, as do genetic factors. They cause the hair follicles to shrink, eventually becoming so small that they are invisible, leading to the appearance of baldness. While treatment is not necessary, side effects including psychological stress and loss of self-esteem due to change in appearance can be experienced.
Spinal cord ischemia/reperfusion injury is a stress injury to the spinal cord. Therefore, research on the expression of stress-related protein in neurons could be of great significance for the pathological mechanism and control measures for spinal cord ischemia/reperfusion injury.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
The Association of Rehabilitation Nurses (ARN) presented Kathleen Brewer-Smyth, PhD RN CRRN, with the 2013 ARN Doctorate-Prepared Researcher Role Award. Dr. Brewer-Smyth received her award at the 39th Annual ARN Educational Conference, held October 2-5 in Charlotte, NC.
Actavis Group has announced that it has launched Terbinafine hydrochloride tablets in the U.S. Distribution of the product will commence immediately.
› Verified 2 days ago
Edmund Chinchar, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 Jefferson St, Laurel, MS 39440 Phone: 601-426-4000 | |
James Boyd Bronson Ii, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 Jefferson St, Laurel, MS 39440 Phone: 601-426-4000 | |
Teresa Randelle Camp-rogers, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1220 Jefferson St, Laurel, MS 39440 Phone: 601-426-4000 Fax: 601-399-6281 | |
Dr. Michael Gast, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 Jefferson St, Laurel, MS 39440 Phone: 601-426-4000 Fax: 601-399-6184 | |
Rebekah Kollar, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 Jefferson St, Laurel, MS 39440 Phone: 601-426-4000 Fax: 601-426-4105 | |
Dr. George M Loukatos, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 Jefferson St, Laurel, MS 39440 Phone: 601-426-4415 | |
Dr. Thomas James Bailey, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 Jefferson St, Laurel, MS 39440 Phone: 601-426-4000 Fax: 601-399-6281 |